Public Employees Retirement Association of Colorado’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Hold
19,331
﹤0.01% 688
2026
Q1
$1.09M Hold
19,331
﹤0.01% 663
2025
Q4
$1.15M Hold
19,331
﹤0.01% 647
2025
Q3
$1.05M Sell
19,331
-207
-1% -$11.8K ﹤0.01% 675
2025
Q2
$1.07M Sell
19,538
-263
-1% -$15.5K ﹤0.01% 654
2025
Q1
$1.4M Hold
19,801
0.01% 577
2024
Q4
$1.3M Hold
19,801
0.01% 615
2024
Q3
$1.39M Hold
19,801
0.01% 597
2024
Q2
$1.63M Sell
19,801
-1,281
-6% -$107K 0.01% 540
2024
Q1
$1.84M Sell
21,082
-929
-4% -$83.2K 0.01% 520
2023
Q4
$2.12M Sell
22,011
-1,095
-5% -$96.9K 0.01% 491
2023
Q3
$2.04M Sell
23,106
-625
-3% -$55.6K 0.01% 480
2023
Q2
$2.06M Hold
23,731
0.01% 504
2023
Q1
$2.31M Hold
23,731
0.01% 483
2022
Q4
$2.46M Hold
23,731
0.01% 483
2022
Q3
$2.01M Hold
23,731
0.01% 504
2022
Q2
$1.97M Hold
23,731
0.01% 517
2022
Q1
$1.83M Sell
23,731
-2,458
-9% -$206K 0.01% 587
2021
Q4
$2.31M Hold
26,189
0.01% 551
2021
Q3
$2.02M Hold
26,189
0.01% 568
2021
Q2
$2.19M Hold
26,189
0.01% 563
2021
Q1
$1.98M Hold
26,189
0.01% 565
2020
Q4
$2.3M Sell
26,189
-197,133
-88% -$15.6M 0.01% 496
2020
Q3
$17M Sell
223,322
-3,867
-2% -$391K 0.09% 172
2020
Q2
$28M Buy
227,189
+20,300
+10% +$2.02M 0.16% 106
2020
Q1
$17.5M Buy
206,889
+149
+0.1% +$12.8K 0.12% 134
2019
Q4
$17.5M Buy
206,740
+11,900
+6% +$899K 0.1% 182
2019
Q3
$13.1M Buy
194,840
+66,700
+52% +$5.14M 0.08% 221
2019
Q2
$11M Buy
128,140
+101,902
+388% +$8.72M 0.07% 249
2019
Q1
$2.33M Sell
26,238
-6,443
-20% -$597K 0.01% 490
2018
Q4
$2.78M Sell
32,681
-74
-0.2% -$7.04K 0.02% 450
2018
Q3
$3.18M Sell
32,755
-33
-0.1% -$3.29K 0.02% 468
2018
Q2
$3.09M Sell
32,788
-65
-0.2% -$5.69K 0.02% 461
2018
Q1
$2.66M Sell
32,853
-1,324
-4% -$114K 0.02% 497
2017
Q4
$3.05M Buy
34,177
+1,112
+3% +$96.7K 0.02% 473
2017
Q3
$3.08M Sell
33,065
-691
-2% -$61.1K 0.02% 447
2017
Q2
$3.07M Buy
33,756
+74
+0.2% +$6.73K 0.02% 457
2017
Q1
$2.96M Sell
33,682
-69
-0.2% -$6.14K 0.02% 470
2016
Q4
$2.8M Sell
33,751
-21
-0.1% -$1.81K 0.02% 475
2016
Q3
$3.13M Sell
33,772
-1,207
-3% -$114K 0.03% 462
2016
Q2
$2.72M Sell
34,979
-1,011
-3% -$85.9K 0.02% 502
2016
Q1
$2.97M Sell
35,990
-1,785
-5% -$145K 0.02% 485
2015
Q4
$3.96M Buy
37,775
+42
+0.1% +$4.39K 0.03% 448
2015
Q3
$3.97M Sell
37,733
-52
-0.1% -$6.95K 0.04% 448
2015
Q2
$5.17M Sell
37,785
-2,623
-6% -$325K 0.04% 412
2015
Q1
$5.04M Sell
40,408
-65,713
-62% -$6.96M 0.04% 425
2014
Q4
$9.59M Sell
106,121
-80
-0.1% -$6.65K 0.08% 263
2014
Q3
$7.66M Sell
106,201
-45
-0% -$2.96K 0.07% 304
2014
Q2
$6.61M Sell
106,246
-49,829
-32% -$3.01M 0.06% 355
2014
Q1
$10.6M Sell
156,075
-18
-0% -$1.33K 0.09% 239
2013
Q4
$11M Buy
156,093
+80
+0.1% +$5.43K 0.09% 239
2013
Q3
$11.3M Buy
156,013
+503
+0.3% +$33.4K 0.1% 217
2013
Q2
$8.68M Buy
+155,510
New +$9.69M 0.08% 261

Other funds holding BMRN

Public Employees Retirement Association of Colorado's BMRN Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 19,331 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Public Employees Retirement Association of Colorado first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $28M in Q2 2020. 352 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Public Employees Retirement Association of Colorado held 19,331 shares of BioMarin Pharmaceuticals worth $1.11M as of Q2 2026.
  • Public Employees Retirement Association of Colorado left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #688 holding.
  • Public Employees Retirement Association of Colorado first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Public Employees Retirement Association of Colorado's BioMarin Pharmaceuticals position peaked at $28M in Q2 2020.
  • 352 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.